Literature DB >> 30725350

High fat diet administration leads to the mitochondrial dysfunction and selectively alters the expression of class 1 GLUT protein in mice.

Dhruv Jha1, Papiya Mitra Mazumder2.   

Abstract

Metabolic syndrome is an agglomeration of disorders including obesity, diabetes and cardiovascular diseases and characterized as chronic mild inflammation which elevates the circulatory inflammatory markers. This could be due to mitochondrial dysfunction, oxidative stress and hypoxia as a consequence of high fat diet (HFD) intake. The present study focuses on the effects of HFD on lactate and mitochondrial metabolism as well as tissue dependent changes in glucose transporter (GLUT) expression in liver, skeletal muscles and adipose tissue of mouse. Lactate dehydrogenase (LDH) and mitochondrial dysfunction established the link between the occurrences of metabolic stress due to HFD. In this work, it was observed that chronic HFD administration aggravated the metabolic alterations by causing reduced ATP production, imbalanced oxidative stress and altered class 1 GLUTs expression. Chronic HFD significantly reduced (p < 0.001) the superoxide dismutase (SOD), catalase (CAT) activities alongside elevated liver injury markers AST and ALT. This in turn causes decreased ATP/ADP ratio, mitochondrial dysfunction and exacerbated LDH levels. This imbalance further led to altered GLUT expression in hepatic cells, adipose tissue and skeletal muscles. HFD significantly (p < 0.001) upregulated the GLUT 1 and 3 expressions while significant downregulated (p < 0.001) GLUT 2 and 4 expression in liver, skeletal muscles and white adipose tissue. These results revealed the link between class 1 GLUTs, mitochondrial dysfunction and HFD-induced metabolic disorder. It can be concluded that HFD impacts mitochondrial metabolism and reprograms tissue-dependent glucose transporter.

Entities:  

Keywords:  GLUT 1–4; High fat diet; LDH; Liver; Mitochondrial dysfunction; Skeletal muscles; White adipose tissue

Mesh:

Substances:

Year:  2019        PMID: 30725350     DOI: 10.1007/s11033-019-04623-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  52 in total

1.  Lactic dehydrogenase activity in blood.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

2.  The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients.

Authors:  X J Hu; F Peng; H Q Zhou; Z H Zhang; W Y Cheng; H F Feng
Journal:  Biochim Biophys Acta       Date:  2000-06-01

3.  Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro.

Authors:  C Carlsson; L A Borg; N Welsh
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

4.  Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes.

Authors:  M M Sandqvist; J W Eriksson; P A Jansson
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

5.  Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

Authors:  Gabriella Milan; Marnie Granzotto; Alessandro Scarda; Alessandra Calcagno; Claudio Pagano; Giovanni Federspil; Roberto Vettor
Journal:  Obes Res       Date:  2002-11

Review 6.  Regulation of glucose transport by hypoxia.

Authors:  J Z Zhang; A Behrooz; F Ismail-Beigi
Journal:  Am J Kidney Dis       Date:  1999-07       Impact factor: 8.860

Review 7.  The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

Authors:  Andrew P Halestrap; David Meredith
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

8.  Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance.

Authors:  Seiichi Yasuda; Shigeki Arii; Akira Mori; Naoki Isobe; Weige Yang; Hideaki Oe; Akihisa Fujimoto; Yoshikuni Yonenaga; Hiromi Sakashita; Masayuki Imamura
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

9.  Mitochondrial dysfunction in the elderly: possible role in insulin resistance.

Authors:  Kitt Falk Petersen; Douglas Befroy; Sylvie Dufour; James Dziura; Charlotte Ariyan; Douglas L Rothman; Loretta DiPietro; Gary W Cline; Gerald I Shulman
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

Review 10.  Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins.

Authors:  I Stuart Wood; Paul Trayhurn
Journal:  Br J Nutr       Date:  2003-01       Impact factor: 3.718

View more
  5 in total

Review 1.  ATP Secretion and Metabolism in Regulating Pancreatic Beta Cell Functions and Hepatic Glycolipid Metabolism.

Authors:  Jing Li; Han Yan; Rui Xiang; Weili Yang; Jingjing Ye; Ruili Yin; Jichun Yang; Yujing Chi
Journal:  Front Physiol       Date:  2022-06-21       Impact factor: 4.755

2.  Dietary Choline Alleviates High-Fat Diet-Induced Hepatic Lipid Dysregulation via UPRmt Modulated by SIRT3-Mediated mtHSP70 Deacetylation.

Authors:  Yu-Feng Song; Hua Zheng; Zhi Luo; Christer Hogstrand; Zhen-Yu Bai; Xiao-Lei Wei
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

3.  Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses.

Authors:  Xiaoling Chen; Shufeng Wang; Yi Huang; Xia Zhao; Xu Jia; Gang Meng; Qian Zheng; Mengjun Zhang; Yuzhang Wu; Li Wang
Journal:  iScience       Date:  2020-03-13

4.  Biomarkers for the toxicity of sublethal concentrations of triclosan to the early life stages of carps.

Authors:  Owias Iqbal Dar; Sunil Sharma; Kirpal Singh; Anket Sharma; Renu Bhardwaj; Arvinder Kaur
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

Review 5.  Improving Age-Related Cognitive Decline through Dietary Interventions Targeting Mitochondrial Dysfunction.

Authors:  Aleksandra Kaliszewska; Joseph Allison; Matteo Martini; Natalia Arias
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.